EGFR and breast carcinoma: Moreover, Ohno et al. reported that the EVs produced by cells engineered to express the transmembrane domain of the PDGF receptor fused to the GE11 peptide that binds specifically to EGFR were able to efficiently deliver let-7a to EGFR-expressing breast cancer cells.